Powered by OpenAIRE graph
Found an issue? Give us feedback

CAPSULTEK

Unlocking the potential of thermo-sensitive bioactive ingredients through a disruptive encapsulation method
Funder: European CommissionProject code: 873827 Call for proposal: H2020-SMEInst-2018-2020-2
Funded under: H2020 | SME-2 Overall Budget: 985,062 EURFunder Contribution: 689,544 EUR
visibility
download
views
OpenAIRE UsageCountsViews provided by UsageCounts
downloads
OpenAIRE UsageCountsDownloads provided by UsageCounts
995
1K
Description

Functional foods provide additional health benefits beyond its nutritional value by adding certain bioactive ingredients to its basic formulation, like Omega-3, probiotics or vitamins. They are massively consumed, being a long-lasting megatrend in food industry, started in the 80’s, and currently living its best moment. Their generated revenue will grow by 50 % until 2022. 1 out of 4 new food products launched have a functional claim. So, global food industries are eager to increase their functional food products portfolio due to its high consumers’ acceptance, potential for deploying new markets, and higher added value. However, most of these bioactive ingredients are easily vulnerable (prone to oxidation, thermolabile…), so, there is a challenge in assuring their integrity and bioavailability when introducing them in food products (complex matrix!). To protect them they are usually encapsulated. Most encapsulation methods work at high temperature damaging the ingredients. Moreover, most methods are energy-intensive, and entail high production costs. In Bioinicia we are experts in nanoencapsulation, and we have developed CAPSULTEK: an innovative own-developed technology called Electrospraying Assisted by Pressurized Gas of which we have a 1 t/year prototype. With our technology we can work at room temperature, encapsulate any kind of molecule, enhance its stability and extend its shelf-life. Besides, industrially-wise, we can scale it up to reach industrial volumes, to reduce encapsulation costs by 40% and to increase concentration bioactive ingredients by 50%. We need Ph.2 to reach market readiness. We will build an industrial demo plant of 10 tonnes/year and will optimize the processing parameters for Omega-3 and probiotics. We have designed a bold and effective highly scalable business model to make the most of CAPSULTEK. First-line food companies have already stated their interest on it, and we foresee an 8 M€ profit by the fifth year of its commercialization.

Partners
Data Management Plans
  • OpenAIRE UsageCounts
    Usage byUsageCounts
    visibility views 995
    download downloads 1K
  • 995
    views
    1K
    downloads
    Powered byOpenAIRE UsageCounts
Powered by OpenAIRE graph
Found an issue? Give us feedback

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
arrow_drop_down
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::872fad5f992d8778ce5990b71163302e&type=result"></script>');
-->
</script>
For further information contact us at helpdesk@openaire.eu

No option selected
arrow_drop_down